CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Glaxo Group against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Dispensing DevicePFIZERDec 2, 2021
Method Of Obtaining Thermostable Dried Vaccine FormulationsMERCK SHARP & DOHMEFeb 5, 2021
Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 6, 2020
Pharmaceutical Compositions For InhalationVECTURAAug 12, 2019
Dispensing DevicePFIZERJul 19, 2019
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In BioreactorsWYETHSep 20, 2018
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 27, 2018
Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURAMay 1, 2018

Explore Glaxo Group's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol1
Apr 17, 2024Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist5
Sep 7, 2022Medicament Dispenser1
May 18, 2022Counter For Use With A Medicament Dispenser1
Mar 18, 2020Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom1
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol8
Dec 20, 2017Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist3
Oct 11, 2017Hbv Antisense Inhibitors1

Top competitors of Glaxo Group

List of top competitors of Glaxo Group based on patent oppositions.